In conclusion, both cfDII-integrity and cfDII-fragmentation determined by RT-qPCR techniques for ALU elements and GAPDH gene can be useful biomarkers to differentiate HCC from CLD and healthy subjects. This evidence concerns the gene GAPDH and hepatocellular carcinoma.